A federal judge trimmed a lawsuit that accuses Sanofi of cornering the market for an injectable form of a diabetes drug, ...

A drug originally developed to treat type 2 diabetes may protect the heart. Early research shows IC7Fc can lower cholesterol, ...

An experimental drug once known for helping control type 2 diabetes may also fight heart disease. Researchers found IC7Fc ...

Explore the potential of SGLT2 inhibitors for IgAN. Learn how these diabetes drugs slow kidney damage progression when added to standard treatment.

(AP) A panel of federal health experts ruled Thursday that an experimental diabetes drug from Johnson & Johnson is safe and effective, though lingering safety questions must be tracked over the ...

Patients on Eli Lilly and Co.’s experimental diabetes pill lost more weight and had better blood sugar control than those on an older, approved rival from Novo Nordisk A/S in the first head-to-head ...

So the, the question we're investigating in this study is whether the use of GLP-1 receptor agonists, which is *** medication for weight loss and diabetes, um, is associated with *** lower risk of ...

Scientists in Sweden have created a new pill designed to help the body burn fat and control blood sugar in a different way than popular GLP-1 drugs, like Ozempic. While injectable GLP-1s work by ...

However, concerns about the impact of rapid glycemic control on diabetic retinopathy risk ...

A common diabetes medication does not help people with peripheral artery disease (PAD) and without diabetes walk farther, ...